Use of a Low Molecular Weight Preparation of Heparin — ORG 10172 (Lomoparan) in the Critically Ill

Bottiger L.E. The heparin story. In search of the Early History of Heparin. Acta Med Scand 1987; 222: 195–200.

Choay J. , Petitou M. The chemistry of heparin: a way to understand its mode of action. Med J Aust, Heparin suppl, 1986; 144: HS7–10.

Salzman E.W. Low molecular weight heparin. Is small beautiful? N Engl J Med 1986; 315 957–9.

Hemker H.E. The mode of action of heparin in plasma. In: Verstraete M. , Vermylen J. , Lijnen H.R. , Arnont J (eds). Thromb Haemostas, Leuven University Press 1977; 17–32.

Fareed J. , Walenga J.M. , Hoppensteadt D. , Huan X. , Nonn R. Biochemical and pharmacologic inequivalence of low molecular weight heparins. Ann NY Acad Sci 1989; 556: 333–53.

Meuleman D.G. , Hobbelen P.M.J. , Van Dedem G. , Moelker H.C.T. A novel antithrombotic heparinoid (Org 10172) devoid of bleeding inducing capacity: A survey of its pharmacological properties in experimental animal models. Thromb Res 1982; 27: 353–63.

Bradbrook I.D. , Magnani H.N. , Moelker H.C.T. Org 10172: a low molecular weight heparinoid anticoagulant with a long half-life in man. Br J Clin Pharmacol 1987; 23: 667–75.

Ljunberg B. , Blomback M. Johnsson H, Lins LE. A single dose of low molecular weight heparin fragment for anticoagulation during haemodialysis. Clin Nephrol 1987; 27: 31–45.

Schrader J. , Stibbe W. , Armstrong V.W. Comparison of low molecular weight heparin to standard heparin in hemodialysis/hemofiltration. Kidney Int 1988; 33: 890–896.

Schrader J. , Kandt M. , Zurcher C. , Kostering H. , Scheler F. Comparison of unfractionated heparin and low molecular weight heparin during long term use in chronic haemodialysis and haemofiltration patients. Haemostasis 1986; 16 Supplement 2: 48–58.

Ireland H. , Lane D.A. , Flynn A. , Anastassiadies E. , Curtis J.R. The anticoagulant effect of heparinoid Org 10172 during haemodialysis: an objective assessment. Thromb Haemost 1986; 55: 271–5.

Eriksson B.I. , Zachrisson B.E. , Teger-Nilsson A.C. , Rissberg B. Thrombosis prophylaxis with low molecular weight heparin in total hip replacement. Br J Surg 1988; 75: 1053–1057.

Koller M. , Schoch U. , Buchmann P. , Langiader F. , vonFelter A. , Frick P.G. Low molecular weight heparin (KABI 2165) as thromboprophylaxis in elective visceral surgery. Thromb Haemost 1986; 56: 243–246.

Albada J. , Nieuwenhuis H.K. , Sixma J.J. Treatment of acute venous thromboemolism with low molecular weight heparin (FRAGMIN). Circulation 1989; 80: 935–940.

Bratt G. , Tornebohm E. , Granqvist S. , Aberg W. , Lockner D. A comparison between low molecular weight heparin (KABI 2165) and standard heparin in the intravenous treatment of deep venous thrombosis. Throm Haemost 1985; 54: 813–817.

Handeland G.F. , Abildgaard U. , Holm H.A. , Arnesen K.E. Dose adjusted heparin treatment of deep venous thrombosis: A comparison of unfractionated and low molecular weight heparin. Eur J Clin Pharmacol 1990; 39: 107–112.

Cate H Ten , Henny C.P. , Buller H.R. , Cate JW Ten , Magnani H.N. Use of a heparinoid in patients with haemorrhagic stroke and thromboembolic disease. Ann Neurol 1984; 15: 268–270.

Schrader J. , Tonnis H.J. , Schler F. Long term intraperitoneal application of low molecular weight heparin in a continuous ambulatory peritoneal dialysis patient with deep vein thrombosis. Nephron 1986; 42: 83–84.

Biller J. , Massey E.W. , Marler J.R. A dose escalation study of Org 10172 (low molecular weight heparinoid) in stroke. Neurology 1989; 39: 262–265.

Nieuwenhuis H.K. , Sixma J.J. Treatment of disseminated intravascular coagulation in acute promyelocytic leukemia with low molecular weight heparinoid Org 10172. Cancer 1986; 58: 761–764.

Kiers L. , Grigg L.E. , Cade J.F. , Street P.R. , Chong B.H. Use of ORG 10172 in the treatment of heparin induced thrombocytopenia and thrombosis. Aust NZ J Med 1986; 16: 719.

Verstraete M. Pharmacotherapeutic aspects of Unfractionated and Low Molecular Weight Heparins. Drugs 1990; 40: 498–530.

Rowlings P.A. , Mansberg R. , Rosenberg Mc . The use of molecular weight heparinoid (ORG 10172) for extracorporeal procedures in patients with heparin dependent thrombocytopaenia and thrombosis. Aust NZ Med J 1991; 21: 52–54.